Cipla
Search results
Insights from the leading minds in our industry. Explore. The Lupin Foundation works in over 4,500 villages to ensure sustainable development. Our Mission. Delivering on our promise toward innovative science and healthcare for more than five decades. How We Began.
Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai. It is one of the largest generic pharmaceutical companies by revenue globally. The company's key focus areas include paediatrics, cardiovascular, anti-infectives, diabetology, asthma and anti-tuberculosis.
Established in 1968 by our visionary founder, Dr. Desh Bandhu Gupta, Lupin has evolved from humble beginnings to become a global healthcare leader. Headquartered in Mumbai, India, we have expanded our footprint across the U.S., LATAM, APAC and EMEA regions, operating in over 100 countries and offering adiverse portfolio of over 1,000 products.
Lupin is a global pharmaceutical company offering Branded and Generic Formulations, Biosimilars and Active Pharmaceutical Ingredients (APIs). Founded over 50 years ago, Lupin today is a...
Jun 26, 2024 · Lupin Limited Stock Price Today, Live NSE Share Price: Get the latest Lupin Limited news, company updates, quotes, tips, historical charts, 52 week high low, market performance financial reports and many more at NSE India.
Lupin is a confluence ground for Passion and Profession. We believe that passion is the fuel for propelling one’s career graph. We capitalize and nurture the performance potential of our people to garner superlative Patient Xperiences.
6 days ago · Lupin Ltd appointed Abdelaziz Toumi as CEO of its new subsidiary, Lupin Manufacturing Solutions (LMS). Toumi, with over 20 years in biotech, pharma, and CDMO sectors, has held roles at Bayer, Merck, and Lonza.
Lupin develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the U.S., India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions.
4 days ago · About Lupin. Lupin Ltd., incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 73,881.50 Crore) operating in Pharmaceuticals sector. Lupin Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Services, Export Incentives and Other Operating Revenue for the year ending 31-Mar-2023.
View the latest Lupin Ltd. (LUPIN) stock price, news, historical charts, analyst ratings and financial information from WSJ.
